Inflammation, malnutrition and atherosclerosis in end-stage renal disease: A global perspective

被引:45
作者
Nascimento, MM [1 ]
Pecoits, R [1 ]
Lindholm, B [1 ]
Riella, MC [1 ]
Stenvinkel, P [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Renal Med, Div Renal Med, SE-14186 Stockholm, Sweden
关键词
inflammation; malnutrition; atherosclerosis; developing countries;
D O I
10.1159/000063559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
End-stage renal disease (ESRD) is characterized by an exceptional cardiovascular mortality rate. Although traditional risk factors are common in ESRD patients, they alone may not be sufficient to account for the high prevalence of cardiovascular disease (CVD). Recent evidence demonstrated that chronic inflammation, a non-traditional risk factor which is commonly observed in ESRD patients, may cause malnutrition and progressive atherosclerotic CVD by several pathogenetic mechanisms. Although both malnutrition and inflammation have been shown to be strong predictors of cardiovascular mortality in ESRD patients, it must be remembered that the majority of studies describing the presence of inflammation and malnutrition have been performed in Western and Asian industrialized countries. As it is evident that the prevalence of malnutrition and inflammation may differ markedly between different regions of the world and developing countries face a much higher prevalence of chronic infectious diseases, comparative inter-regional studies focusing on the etiology and prevalence of the malnutrition, inflammation and atherosclerosis syndrome are warranted. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:454 / 458
页数:5
相关论文
共 19 条
[1]  
Aguilera A, 2001, PERITON DIALYSIS INT, V21, pS152
[2]   The African enigma: Low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children [J].
Campbell, DI ;
Warren, BF ;
Thomas, JE ;
Figura, N ;
Telford, JL ;
Sullivan, PB .
HELICOBACTER, 2001, 6 (04) :263-267
[3]   Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients [J].
Caravaca, F ;
Arrobas, M ;
Pizarro, JL ;
Sanchez-Casado, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (04) :776-782
[4]  
Churchill DN, 1996, J AM SOC NEPHROL, V7, P198
[5]   Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR [J].
Farsak, B ;
Yildirir, A ;
Akyön, Y ;
Pinar, A ;
Öç, M ;
Böke, E ;
Kes, S ;
Tokgözoglu, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (12) :4408-4411
[6]  
Jansen MAM, 2001, J AM SOC NEPHROL, V12, P157, DOI 10.1681/ASN.V121157
[7]  
Laws R A, 2000, J Ren Nutr, V10, P139, DOI 10.1053/jren.2000.7412
[8]   Evidence for infectious agents in cardiovascular disease and atherosclerosis [J].
Leinonen, M ;
Saikku, P .
LANCET INFECTIOUS DISEASES, 2002, 2 (01) :11-17
[9]  
Noh H, 1998, PERITON DIALYSIS INT, V18, P387
[10]   Nephrology, dialysis and transplantation in Brazil [J].
Noronha, IL ;
Schor, N ;
Coelho, SN ;
Jorgetti, V ;
Romao, JE ;
Zatz, R ;
Burdmann, EA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) :2234-2243